Study of drug intervention in emergence agitation after strabismus surgery in children

Retrospective and Prospective study of drug intervention in emergence agitation after strabismus surgery in children

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300068004

Enrollment

Unknown

Registered

2023-02-02

Start date

2023-02-02

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

strabismus

Interventions

Test group:subconjunctival injection of ropivacaine

Control group:subconjunctival injection of normal saline

Eligibility

Sex/Gender

All

Age

4 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Age 4-18 years; 2. ASA level I~II; 3. Monocular strabismus surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. ASA classification >= Level III; 2. Binocular surgery; 3. Eye diseases that may affect the operation of strabismus in ophthalmic examination; 4. Premature infants, low birth weight infants, infants with previous perinatal history and obvious sequelae; 5. Dysfunction of heart, brain, liver, kidney or other important organs, abnormal coagulation function before operation; 6. Respiratory diseases that cannot be treated with intravenous general anesthesia before operation.

Design outcomes

Primary

Measure	Time frame
PAED scale;FLACC behavior scale;pain scale;	—

Secondary

Measure	Time frame
blood pressure;heart rate;pulse oxygen saturation;respiratory rate;	—

Countries

China

Contacts

Public ContactDehai Zhu

Peking University First Hospital

13651103036@163.com+86 10 6400 4150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026